Results 11 to 20 of about 16,959 (263)

Self‐reported quality of life in symptomatic and asymptomatic women with X‐linked adrenoleukodystrophy

open access: yesBrain and Behavior, 2023
Background Up to 80% of women with X‐linked adrenoleukodystrophy (X‐ALD) develop symptoms of myelopathy and peripheral neuropathy during their lifetime. The study's objective was to compare symptomatic versus asymptomatic women with X‐ALD regarding their
Lisa Schäfer   +3 more
doaj   +1 more source

Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy

open access: yesBrain : a journal of neurology, 2021
Metachromatic leukodystrophy is a lethal metabolic leukodystrophy, with emerging treatments for early disease stages. Biomarkers to measure disease activity are required for clinical assessment and treatment follow-up.
Shanice Beerepoot   +10 more
semanticscholar   +1 more source

Guanabenz ameliorates disease in vanishing white matter mice in contrast to sephin1

open access: yesAnnals of Clinical and Translational Neurology, 2022
Objective Vanishing white matter (VWM) is a leukodystrophy, characterized by stress‐sensitive neurological deterioration and premature death. It is currently without curative treatment. It is caused by bi‐allelic pathogenic variants in the genes encoding
Diede Witkamp   +11 more
doaj   +1 more source

Genetic analysis of 20 patients with hypomyelinating leukodystrophy by trio-based whole-exome sequencing

open access: yesJournal of Human Genetics, 2021
Hypomyelinating leukodystrophies (HLDs) are a rare group of disorders characterized by myelin deficit of the brain-based on MRI. Here, we studied 20 patients with unexplained HLD to uncover their genetic etiology through whole-exome sequencing (WES ...
Huifang Yan   +19 more
semanticscholar   +1 more source

The Leukodystrophies [PDF]

open access: yesSeminars in Neurology, 2014
Leukodystrophies are a group of genetically determined disorders that affect development or maintenance of central nervous system myelin. Leukodystrophies have a reported incidence of 1 in 7500 live births, but fewer than half of patients receive a specific diagnosis.
Hannah B, Gordon   +2 more
openaire   +2 more sources

Anticipatory banking of samples enables diagnosis of adenylosuccinase deficiency following molecular autopsy in an infant with vacuolating leukoencephalopathy

open access: yesAmerican Journal of Medical Genetics Part A, Volume 191, Issue 1, Page 234-237, January 2023., 2023
Abstract Adenylosuccinase deficiency is a rare inborn error of metabolism. We present a newborn who died at 52 days of age with clinical features suggestive of severe epileptic encephalopathy and leukodystrophy of unknown cause. Post‐mortem examination showed an unusual vacuolar appearance of the brain.
Spatikha Sitaram   +11 more
wiley   +1 more source

Pathology of the neurovascular unit in leukodystrophies

open access: yesActa Neuropathologica Communications, 2021
The blood–brain barrier is a dynamic endothelial cell barrier in the brain microvasculature that separates the blood from the brain parenchyma. Specialized brain endothelial cells, astrocytes, neurons, microglia and pericytes together compose the ...
Parand Zarekiani   +5 more
doaj   +1 more source

Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy

open access: yesGlia, 2021
Globoid cell leukodystrophy (GLD), also known as Krabbe disease, is a lysosomal storage disorder causing extensive demyelination in the central and peripheral nervous systems.
M. Feltri   +5 more
semanticscholar   +1 more source

Quantitative MRI in leukodystrophies

open access: yesNeuroImage: Clinical, 2023
Leukodystrophies constitute a large and heterogeneous group of genetic diseases primarily affecting the white matter of the central nervous system. Different disorders target different white matter structural components. Leukodystrophies are most often progressive and fatal.
Stellingwerff, Menno D   +4 more
openaire   +6 more sources

Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy

open access: yesAnnals of Clinical and Translational Neurology, 2021
Objective To prospectively determine the value of optical coherence tomography (OCT) as a surrogate outcome measure for the progression of myelopathy in males with adrenoleukodystrophy.
Wouter J. C. vanBallegoij   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy